Eton Pharmaceuticals, Inc.
NASDAQ:ETON · NASDAQ Global Market
-$0.46 today
Vol 0.58M · Avg 0.43M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+139.35%
Period High
$35.00
Period Low
$13.50
Latest
$32.48
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
RAPT Therapeutics, Inc.
RAPT
$959.26M
Lexicon Pharmaceuticals, Inc.
NASDAQ:LXRX
$881.73M
Omeros Corporation
NASDAQ:OMER
$732.44M
Monopar Therapeutics Inc.
NASDAQ:MNPR
$445.49M
Ocugen, Inc.
NASDAQ:OCGN
$428.23M
Lineage Cell Therapeutics, Inc.
AMEX:LCTX
$305.39M
Bicycle Therapeutics plc
NASDAQ:BCYC
$277.58M
Neumora Therapeutics, Inc. Common Stock
NASDAQ:NMRA
$270.51M
Fulcrum Therapeutics, Inc.
NASDAQ:FULC
$188.85M
ADC Therapeutics S.A.
NYSE:ADCT
$138.00M
What is the latest ETON filing?
The latest filing shown is 4 dated Jun 17, 2026.
How many recent filings does ETON have?
Intrinsic Alpha currently shows 20 recent filings for ETON.
Explore More
Continue the stock analysis
Jump to another research area for this company.